USP13 and breast cancer: Based on data from the ULACAN database (http://ualcan.path.uab.edu/), we found a significantly higher USP13 expression (p < 0.01) in highly metastatic triple-negative breast cancers compared to the other two breast cancer subclasses (Fig. 1a and Table S1).